On the other hand, BRCA1 and BRCA2 carriers face a 50–59% and 42–51% breast cancer risk, and 34–45% and 13–21% ovarian cancer risk respectively, as well as a two-to threefold risk of endometrial cancer [9]. This evidence concerns the gene BRCA1 and breast carcinoma.